Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acorda Therapeutics Inc.

www.acorda.com

Latest From Acorda Therapeutics Inc.

The Flaws With IPR Patent Review: Acorda CEO Weighs In On Allergan Move

Allergan’s unusual arrangement to try to avoid IPR proceedings on Restasis made headlines last week. Our article suggesting the move is potentially damaging for the image of the biopharma sector as a whole prompted a response from Acorda CEO Ron Cohen.

Intellectual Property Legal Issues

Deal Watch: Inventiva Expands Collaborations With Boehringer, AbbVie

French biotech expands fibrosis partnership with Boehringer Ingelheim, and a co-development pact with AbbVie around ROR gamma inverse agonists. Helsinn signs on to detail Novartis' Zykadia in the US.

Deals M & A

Keeping Track: US FDA Refuses To File Acorda, SteadyMed NDAs

Issues involving inspectional readiness and the drug master production record cited in agency's refusal to review Acorda's Inbrija in Parkinson's disease; SteadyMed faces request for additional design verification and validation testing for drug/device combo Trevyent in pulmonary arterial hypertension.

United States FDA

Acorda Enacts 'Poison Pill' In Effort To Stave Off Scopia

After the hedge fund Scopia called on Acorda to investigate the possibility of a sale, the biotech's argument for its current direction faltered due to an FDA refuse-to-file letter for Inbrija. Acorda then adopted a shareholder rights plan to buy time.

Business Strategies M & A
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register